ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,187.61
-0.81%
Dow Jones
38,500.63
-0.91%
Gold vs US Dollar
2,342.925
-0.70%
Brent Oil
83.515
-0.96%
Bitcoin
67,491.30
-1.18%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Baudax Bio Inc (BXRX)

  7. Baudax Bio Inc (BXRX) News

Baudax Bio (BXRX)

Baudax Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BXRX
DateTimeSourceHeadlineSymbolCompany
15/11/202322:25Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:BXRXBaudax Bio Inc
15/11/202321:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BXRXBaudax Bio Inc
25/10/202312:57Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BXRXBaudax Bio Inc
13/10/202312:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BXRXBaudax Bio Inc
11/10/202321:47Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BXRXBaudax Bio Inc
10/10/202312:00Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BXRXBaudax Bio Inc
06/10/202313:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BXRXBaudax Bio Inc
29/09/202312:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BXRXBaudax Bio Inc
26/09/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BXRXBaudax Bio Inc
26/09/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BXRXBaudax Bio Inc
21/09/202322:30Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BXRXBaudax Bio Inc
21/09/202321:48Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:BXRXBaudax Bio Inc
07/09/202322:16Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BXRXBaudax Bio Inc
07/09/202321:10Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BXRXBaudax Bio Inc
07/09/202321:06Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:BXRXBaudax Bio Inc
05/09/202322:24Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:BXRXBaudax Bio Inc
05/09/202321:13Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BXRXBaudax Bio Inc
05/09/202321:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BXRXBaudax Bio Inc
25/08/202321:01Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:BXRXBaudax Bio Inc
25/08/202313:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BXRXBaudax Bio Inc
24/08/202322:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BXRXBaudax Bio Inc
24/08/202322:05Edgar (US Regulatory)Form 8-A12G - Registration of securities [Section 12(g)]NASDAQ:BXRXBaudax Bio Inc
21/08/202313:05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BXRXBaudax Bio Inc
21/08/202313:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BXRXBaudax Bio Inc
18/08/202321:40Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BXRXBaudax Bio Inc
17/08/202313:05Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BXRXBaudax Bio Inc
16/08/202313:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BXRXBaudax Bio Inc
15/08/202312:30Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:BXRXBaudax Bio Inc
09/08/202322:28Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BXRXBaudax Bio Inc
09/08/202322:27Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:BXRXBaudax Bio Inc
 Showing the most relevant articles for your search:NASDAQ:BXRX

Your Recent History

LSE
IGP
Intercede
NASDAQ
BBOX
BIT
EXAI
Expert AI
AQSE
COG.GB
Cambridge Cognition
EU
ALMER
Sapmer
USOTC
NECA
New America Energy (PK)
NASDAQ
IDYA
IDEAYA Biosciences
LSE
JLT
Jardine Lloyd Thompson
NASDAQ
GLTO
Galecto
NASDAQ
AAXIBXX
Morgan Stanley Finance L...
LSE
AMLR
Amlin
NYSE
EW
Edwards Lifesciences
NYSE
CRGY
Crescent Energy
NASDAQ
ALTM
Altus Midstream
NASDAQ
AMR
Alta Mesa Resources
LSE
FTC
Filtronic
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved